Improvement of biological activity and proteolytic stability of peptides by coupling with a cyclic peptide

This publication has 16 references indexed in Scilit:

• Hybrid peptides constructed from RES-701-1, an endothelin B receptor antagonist, and endothelin; binding selectivity for endothelin receptors and their pharmacological activity
  Bioorganic & Medicinal Chemistry, 1998
• RES-701-1/endothelin-1 hybrid peptide having a potent binding activity for type B receptor
  Bioorganic & Medicinal Chemistry Letters, 1997
• Solution structure of endothelin B receptor selective antagonist RES-701-1 determined by 1H NMR spectroscopy
  Bioorganic & Medicinal Chemistry, 1995
• RES-701-1, comparative study of the synthetic and the microbial-origin compounds
  Bioorganic & Medicinal Chemistry Letters, 1995
• RES-701-1, a novel and selective endothelin type B receptor antagonist produced by Streptomyces sp. RE-701. II. Determination of the primary sequence.
  The Journal of Antibiotics, 1994
• Conformation of a heptapeptide substrate bound to protein farnesyltransferase
  Biochemistry, 1993
• Design and synthesis of a C7 mimetic for the predicted .gamma.-turn conformation found in several constrained RGD antagonists
  Journal of Medicinal Chemistry, 1992
• Solution structure of endothelin-3 determined using NMR spectroscopy
  Biochemistry, 1992
• Sequence requirement for peptide recognition by rat brain p21ras protein farnesyltransferase.
  Proceedings of the National Academy of Sciences, 1991
• Variants of the cell recognition site of fibronectin that retain attachment-promoting activity.
  Proceedings of the National Academy of Sciences, 1984